Literature DB >> 12054859

Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.

Anna Niedzwiecka1, Joseph Marcotrigiano, Janusz Stepinski, Marzena Jankowska-Anyszka, Aleksandra Wyslouch-Cieszynska, Michal Dadlez, Anne-Claude Gingras, Pawel Mak, Edward Darzynkiewicz, Nahum Sonenberg, Stephen K Burley, Ryszard Stolarski.   

Abstract

mRNA 5'-cap recognition by the eukaryotic translation initiation factor eIF4E has been exhaustively characterized with the aid of a novel fluorometric, time-synchronized titration method, and X-ray crystallography. The association constant values of recombinant eIF4E for 20 different cap analogues cover six orders of magnitude; with the highest affinity observed for m(7)GTP (approximately 1.1 x 10(8) M(-1)). The affinity of the cap analogues for eIF4E correlates with their ability to inhibit in vitro translation. The association constants yield contributions of non-covalent interactions involving single structural elements of the cap to the free energy of binding, giving a reliable starting point to rational drug design. The free energy of 7-methylguanine stacking and hydrogen bonding (-4.9 kcal/mol) is separate from the energies of phosphate chain interactions (-3.0, -1.9, -0.9 kcal/mol for alpha, beta, gamma phosphates, respectively), supporting two-step mechanism of the binding. The negatively charged phosphate groups of the cap act as a molecular anchor, enabling further formation of the intermolecular contacts within the cap-binding slot. Stabilization of the stacked Trp102/m(7)G/Trp56 configuration is a precondition to form three hydrogen bonds with Glu103 and Trp102. Electrostatically steered eIF4E-cap association is accompanied by additional hydration of the complex by approximately 65 water molecules, and by ionic equilibria shift. Temperature dependence reveals the enthalpy-driven and entropy-opposed character of the m(7)GTP-eIF4E binding, which results from dominant charge-related interactions (DeltaH degrees =-17.8 kcal/mol, DeltaS degrees= -23.6 cal/mol K). For recruitment of synthetic eIF4GI, eIF4GII, and 4E-BP1 peptides to eIF4E, all the association constants were approximately 10(7) M(-1), in decreasing order: eIF4GI>4E-BP1>eIF4GII approximately 4E-BP1(P-Ser65) approximately 4E-BP1(P-Ser65/Thr70). Phosphorylation of 4E-BP1 at Ser65 and Thr70 is insufficient to prevent binding to eIF4E. Enhancement of the eIF4E affinity for cap occurs after binding to eIF4G peptides. (c) 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054859     DOI: 10.1016/S0022-2836(02)00328-5

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  142 in total

1.  Dynamical insight into Caenorhabditis elegans eIF4E recognition specificity for mono-and trimethylated structures of mRNA 5' cap.

Authors:  Katarzyna Ruszczyńska-Bartnik; Maciej Maciejczyk; Ryszard Stolarski
Journal:  J Mol Model       Date:  2010-06-10       Impact factor: 1.810

2.  Phosphorylation of eIF4E attenuates its interaction with mRNA 5' cap analogs by electrostatic repulsion: intein-mediated protein ligation strategy to obtain phosphorylated protein.

Authors:  Joanna Zuberek; Aleksandra Wyslouch-Cieszynska; Anna Niedzwiecka; Michal Dadlez; Janusz Stepinski; Wojciech Augustyniak; Anne-Claude Gingras; Zhibo Zhang; Stephen K Burley; Nahum Sonenberg; Ryszard Stolarski; Edward Darzynkiewicz
Journal:  RNA       Date:  2003-01       Impact factor: 4.942

3.  Functional analysis of mRNA scavenger decapping enzymes.

Authors:  Shin-Wu Liu; Xinfu Jiao; Hudan Liu; Meigang Gu; Christopher D Lima; Megerditch Kiledjian
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

4.  Chemical synthesis and binding activity of the trypanosomatid cap-4 structure.

Authors:  Magdalena Lewdorowicz; Yael Yoffe; Joanna Zuberek; Jacek Jemielity; Janusz Stepinski; Ryszard Kierzek; Ryszard Stolarski; Michal Shapira; Edward Darzynkiewicz
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

5.  Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency.

Authors:  Ewa Grudzien; Janusz Stepinski; Marzena Jankowska-Anyszka; Ryszard Stolarski; Edward Darzynkiewicz; Robert E Rhoads
Journal:  RNA       Date:  2004-09       Impact factor: 4.942

6.  Emerging therapeutics targeting mRNA translation.

Authors:  Abba Malina; John R Mills; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

7.  mRNAs biotinylated within the 5' cap and protected against decapping: new tools to capture RNA-protein complexes.

Authors:  Sylwia Bednarek; Vanesa Madan; Pawel J Sikorski; Ralf Bartenschlager; Joanna Kowalska; Jacek Jemielity
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-11-05       Impact factor: 6.237

8.  Backbone resonance assignment of human eukaryotic translation initiation factor 4E (eIF4E) in complex with 7-methylguanosine diphosphate (m7GDP) and a 17-amino acid peptide derived from human eIF4GII.

Authors:  Takaaki Miura; Yasuhiko Shiratori; Nobuo Shimma
Journal:  J Biomol NMR       Date:  2003-11       Impact factor: 2.835

Review 9.  How RNA-Binding Proteins Interact with RNA: Molecules and Mechanisms.

Authors:  Meredith Corley; Margaret C Burns; Gene W Yeo
Journal:  Mol Cell       Date:  2020-04-02       Impact factor: 17.970

10.  Conformational changes induced in the eukaryotic translation initiation factor eIF4E by a clinically relevant inhibitor, ribavirin triphosphate.

Authors:  Laurent Volpon; Michael J Osborne; Hiba Zahreddine; Andrea A Romeo; Katherine L B Borden
Journal:  Biochem Biophys Res Commun       Date:  2013-04-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.